questionsmedicales.fr
Facteurs biologiques
Antigènes
Isoantigènes
Antigènes d'histocompatibilité
Antigènes HLA
Antigènes HLA-D
Antigènes HLA-D : Questions médicales fréquentes
Diagnostic
5
Maladies auto-immunes
Antigènes HLA
Transplantation
Rejet de greffe
Symptômes
5
Symptômes
Maladies auto-immunes
Antigènes HLA
Maladies auto-immunes
Antigènes HLA
Maladies auto-immunes
Maladies auto-immunes
Symptômes
Prévention
5
Prévention
Maladies auto-immunes
Facteurs de risque
Prévention
Vaccination
Réponse immunitaire
Antécédents familiaux
Facteurs de risque
Traitements
5
Immunosuppresseurs
Thérapies ciblées
Antigènes HLA
Maladies auto-immunes
Greffe
Immunosuppresseurs
Thérapies biologiques
Maladies auto-immunes
Efficacité des traitements
Maladies auto-immunes
Complications
5
Rejet de greffe
Complications
Maladies auto-immunes
Complications
Gestion des complications
Suivi médical
Prévisibilité
Suivi médical
Antigènes HLA
Complications
Facteurs de risque
5
Facteurs de risque
Maladies auto-immunes
Sexe
Maladies auto-immunes
Habitudes de vie
Facteurs de risque
Infections
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Antigènes HLA-D : Questions médicales les plus fréquentes",
"headline": "Antigènes HLA-D : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Antigènes HLA-D : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-08",
"dateModified": "2026-01-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Antigènes HLA-D"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Antigènes HLA",
"url": "https://questionsmedicales.fr/mesh/D006680",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes HLA",
"code": {
"@type": "MedicalCode",
"code": "D006680",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes HLA-DP",
"alternateName": "HLA-DP Antigens",
"url": "https://questionsmedicales.fr/mesh/D006682",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes HLA-DP",
"code": {
"@type": "MedicalCode",
"code": "D006682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.420"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chaines alpha des antigènes HLA-DP",
"alternateName": "HLA-DP alpha-Chains",
"url": "https://questionsmedicales.fr/mesh/D059867",
"about": {
"@type": "MedicalCondition",
"name": "Chaines alpha des antigènes HLA-DP",
"code": {
"@type": "MedicalCode",
"code": "D059867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.420.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines bêta des antigènes HLA-DP",
"alternateName": "HLA-DP beta-Chains",
"url": "https://questionsmedicales.fr/mesh/D059868",
"about": {
"@type": "MedicalCondition",
"name": "Chaines bêta des antigènes HLA-DP",
"code": {
"@type": "MedicalCode",
"code": "D059868",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.420.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigènes HLA-DQ",
"alternateName": "HLA-DQ Antigens",
"url": "https://questionsmedicales.fr/mesh/D006683",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes HLA-DQ",
"code": {
"@type": "MedicalCode",
"code": "D006683",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.430"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chaines alpha des antigènes HLA-DQ",
"alternateName": "HLA-DQ alpha-Chains",
"url": "https://questionsmedicales.fr/mesh/D059848",
"about": {
"@type": "MedicalCondition",
"name": "Chaines alpha des antigènes HLA-DQ",
"code": {
"@type": "MedicalCode",
"code": "D059848",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.430.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines bêta des antigènes HLA-DQ",
"alternateName": "HLA-DQ beta-Chains",
"url": "https://questionsmedicales.fr/mesh/D059866",
"about": {
"@type": "MedicalCondition",
"name": "Chaines bêta des antigènes HLA-DQ",
"code": {
"@type": "MedicalCode",
"code": "D059866",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.430.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigènes HLA-DR",
"alternateName": "HLA-DR Antigens",
"url": "https://questionsmedicales.fr/mesh/D006684",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes HLA-DR",
"code": {
"@type": "MedicalCode",
"code": "D006684",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chaines alpha des antigènes HLA-DR",
"alternateName": "HLA-DR alpha-Chains",
"url": "https://questionsmedicales.fr/mesh/D059805",
"about": {
"@type": "MedicalCondition",
"name": "Chaines alpha des antigènes HLA-DR",
"code": {
"@type": "MedicalCode",
"code": "D059805",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.222"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines bêta des antigènes HLA-DR",
"alternateName": "HLA-DR beta-Chains",
"url": "https://questionsmedicales.fr/mesh/D059806",
"about": {
"@type": "MedicalCondition",
"name": "Chaines bêta des antigènes HLA-DR",
"code": {
"@type": "MedicalCode",
"code": "D059806",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chaines HLA-DRB1",
"alternateName": "HLA-DRB1 Chains",
"url": "https://questionsmedicales.fr/mesh/D059811",
"about": {
"@type": "MedicalCondition",
"name": "Chaines HLA-DRB1",
"code": {
"@type": "MedicalCode",
"code": "D059811",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines HLA-DRB3",
"alternateName": "HLA-DRB3 Chains",
"url": "https://questionsmedicales.fr/mesh/D059826",
"about": {
"@type": "MedicalCondition",
"name": "Chaines HLA-DRB3",
"code": {
"@type": "MedicalCode",
"code": "D059826",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines HLA-DRB4",
"alternateName": "HLA-DRB4 Chains",
"url": "https://questionsmedicales.fr/mesh/D059845",
"about": {
"@type": "MedicalCondition",
"name": "Chaines HLA-DRB4",
"code": {
"@type": "MedicalCode",
"code": "D059845",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines HLA-DRB5",
"alternateName": "HLA-DRB5 Chains",
"url": "https://questionsmedicales.fr/mesh/D059847",
"about": {
"@type": "MedicalCondition",
"name": "Chaines HLA-DRB5",
"code": {
"@type": "MedicalCode",
"code": "D059847",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333.937"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chaines HLA-DRB1",
"alternateName": "HLA-DRB1 Chains",
"url": "https://questionsmedicales.fr/mesh/D059811",
"about": {
"@type": "MedicalCondition",
"name": "Chaines HLA-DRB1",
"code": {
"@type": "MedicalCode",
"code": "D059811",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines HLA-DRB3",
"alternateName": "HLA-DRB3 Chains",
"url": "https://questionsmedicales.fr/mesh/D059826",
"about": {
"@type": "MedicalCondition",
"name": "Chaines HLA-DRB3",
"code": {
"@type": "MedicalCode",
"code": "D059826",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines HLA-DRB4",
"alternateName": "HLA-DRB4 Chains",
"url": "https://questionsmedicales.fr/mesh/D059845",
"about": {
"@type": "MedicalCondition",
"name": "Chaines HLA-DRB4",
"code": {
"@type": "MedicalCode",
"code": "D059845",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chaines HLA-DRB5",
"alternateName": "HLA-DRB5 Chains",
"url": "https://questionsmedicales.fr/mesh/D059847",
"about": {
"@type": "MedicalCondition",
"name": "Chaines HLA-DRB5",
"code": {
"@type": "MedicalCode",
"code": "D059847",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.333.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sous-types sérologiques HLA-DR",
"alternateName": "HLA-DR Serological Subtypes",
"url": "https://questionsmedicales.fr/mesh/D059810",
"about": {
"@type": "MedicalCondition",
"name": "Sous-types sérologiques HLA-DR",
"code": {
"@type": "MedicalCode",
"code": "D059810",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR1",
"alternateName": "HLA-DR1 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015798",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR1",
"code": {
"@type": "MedicalCode",
"code": "D015798",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR2",
"alternateName": "HLA-DR2 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015802",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR2",
"code": {
"@type": "MedicalCode",
"code": "D015802",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR3",
"alternateName": "HLA-DR3 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015803",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR3",
"code": {
"@type": "MedicalCode",
"code": "D015803",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR4",
"alternateName": "HLA-DR4 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015804",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR4",
"code": {
"@type": "MedicalCode",
"code": "D015804",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR5",
"alternateName": "HLA-DR5 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015805",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR5",
"code": {
"@type": "MedicalCode",
"code": "D015805",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.968"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR6",
"alternateName": "HLA-DR6 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015808",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR6",
"code": {
"@type": "MedicalCode",
"code": "D015808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.984"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR7",
"alternateName": "HLA-DR7 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015809",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR7",
"code": {
"@type": "MedicalCode",
"code": "D015809",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.992"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR1",
"alternateName": "HLA-DR1 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015798",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR1",
"code": {
"@type": "MedicalCode",
"code": "D015798",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR2",
"alternateName": "HLA-DR2 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015802",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR2",
"code": {
"@type": "MedicalCode",
"code": "D015802",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR3",
"alternateName": "HLA-DR3 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015803",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR3",
"code": {
"@type": "MedicalCode",
"code": "D015803",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR4",
"alternateName": "HLA-DR4 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015804",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR4",
"code": {
"@type": "MedicalCode",
"code": "D015804",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR5",
"alternateName": "HLA-DR5 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015805",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR5",
"code": {
"@type": "MedicalCode",
"code": "D015805",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.968"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR6",
"alternateName": "HLA-DR6 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015808",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR6",
"code": {
"@type": "MedicalCode",
"code": "D015808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.984"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antigène HLA-DR7",
"alternateName": "HLA-DR7 Antigen",
"url": "https://questionsmedicales.fr/mesh/D015809",
"about": {
"@type": "MedicalCondition",
"name": "Antigène HLA-DR7",
"code": {
"@type": "MedicalCode",
"code": "D015809",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.705.552.450.400.440.389.992"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Antigènes HLA-D",
"alternateName": "HLA-D Antigens",
"code": {
"@type": "MedicalCode",
"code": "D006681",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Apostolos P Georgopoulos",
"url": "https://questionsmedicales.fr/author/Apostolos%20P%20Georgopoulos",
"affiliation": {
"@type": "Organization",
"name": "The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA."
}
},
{
"@type": "Person",
"name": "Lisa M James",
"url": "https://questionsmedicales.fr/author/Lisa%20M%20James",
"affiliation": {
"@type": "Organization",
"name": "The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA."
}
},
{
"@type": "Person",
"name": "Arie Admon",
"url": "https://questionsmedicales.fr/author/Arie%20Admon",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Biology, Technion Israel Institute of Technology, Haifa, Israel admon@technion.ac.il Michael.peled@sheba.health.gov.il."
}
},
{
"@type": "Person",
"name": "Spyros A Charonis",
"url": "https://questionsmedicales.fr/author/Spyros%20A%20Charonis",
"affiliation": {
"@type": "Organization",
"name": "The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA."
}
},
{
"@type": "Person",
"name": "Matthew Sanders",
"url": "https://questionsmedicales.fr/author/Matthew%20Sanders",
"affiliation": {
"@type": "Organization",
"name": "The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "HLA-DM and HLA-DO interplay for the peptide editing of HLA class II in healthy tissues and leukemia.",
"datePublished": "2024-07-06",
"url": "https://questionsmedicales.fr/article/39098801",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.beha.2024.101561"
}
},
{
"@type": "ScholarlyArticle",
"name": "HLA-DMB alleles and haplotypes in Ecuador (Cuenca) Amerindians: Importance for HLA and disease studies.",
"datePublished": "2023-03-02",
"url": "https://questionsmedicales.fr/article/36870854",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.humimm.2023.02.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange.",
"datePublished": "2023-05-04",
"url": "https://questionsmedicales.fr/article/37142807",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41589-023-01316-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37251656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/11769351231172604"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Human Leukocyte Antigen (HLA) class II (",
"datePublished": "2023-06-22",
"url": "https://questionsmedicales.fr/article/37426636",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1178546"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Antigènes",
"item": "https://questionsmedicales.fr/mesh/D000941"
},
{
"@type": "ListItem",
"position": 4,
"name": "Isoantigènes",
"item": "https://questionsmedicales.fr/mesh/D007519"
},
{
"@type": "ListItem",
"position": 5,
"name": "Antigènes d'histocompatibilité",
"item": "https://questionsmedicales.fr/mesh/D006649"
},
{
"@type": "ListItem",
"position": 6,
"name": "Antigènes HLA",
"item": "https://questionsmedicales.fr/mesh/D006680"
},
{
"@type": "ListItem",
"position": 7,
"name": "Antigènes HLA-D",
"item": "https://questionsmedicales.fr/mesh/D006681"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Antigènes HLA-D - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Antigènes HLA-D",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Antigènes HLA-D",
"description": "Comment diagnostiquer une incompatibilité HLA-D ?\nQuels tests sont utilisés pour les antigènes HLA-D ?\nLes antigènes HLA-D sont-ils liés à des maladies ?\nQuel rôle joue le typage HLA-D en transplantation ?\nPeut-on détecter les antigènes HLA-D par biopsie ?",
"url": "https://questionsmedicales.fr/mesh/D006681#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Antigènes HLA-D",
"description": "Quels symptômes sont associés aux maladies HLA-D ?\nLes antigènes HLA-D causent-ils des symptômes directs ?\nComment les symptômes varient selon les antigènes HLA-D ?\nLes symptômes sont-ils similaires pour tous les HLA-D ?\nLes symptômes peuvent-ils apparaître soudainement ?",
"url": "https://questionsmedicales.fr/mesh/D006681#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Antigènes HLA-D",
"description": "Peut-on prévenir les maladies liées aux HLA-D ?\nY a-t-il des mesures préventives spécifiques ?\nLe dépistage précoce est-il recommandé ?\nLes vaccinations influencent-elles les antigènes HLA-D ?\nLes antécédents familiaux augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006681#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Antigènes HLA-D",
"description": "Quels traitements sont disponibles pour les maladies HLA-D ?\nLes traitements varient-ils selon le type d'HLA-D ?\nLes greffes nécessitent-elles un traitement immunosuppresseur ?\nPeut-on traiter les maladies HLA-D par des thérapies biologiques ?\nLes traitements sont-ils efficaces pour tous les patients ?",
"url": "https://questionsmedicales.fr/mesh/D006681#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Antigènes HLA-D",
"description": "Quelles complications peuvent survenir avec HLA-D ?\nLes maladies HLA-D peuvent-elles entraîner des complications graves ?\nComment gérer les complications liées aux HLA-D ?\nLes complications sont-elles prévisibles ?\nLes complications varient-elles selon les antigènes HLA-D ?",
"url": "https://questionsmedicales.fr/mesh/D006681#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Antigènes HLA-D",
"description": "Quels sont les facteurs de risque pour les maladies HLA-D ?\nL'âge influence-t-il le risque d'HLA-D ?\nLe sexe joue-t-il un rôle dans les maladies HLA-D ?\nLes habitudes de vie affectent-elles le risque ?\nLes infections antérieures augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006681#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une incompatibilité HLA-D ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test de typage HLA est effectué pour identifier les antigènes HLA-D spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les antigènes HLA-D ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de sérologie et de PCR sont couramment utilisés pour le typage HLA-D."
}
},
{
"@type": "Question",
"name": "Les antigènes HLA-D sont-ils liés à des maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des associations existent entre les antigènes HLA-D et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le typage HLA-D en transplantation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il aide à évaluer la compatibilité entre donneur et receveur pour réduire le risque de rejet."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les antigènes HLA-D par biopsie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une biopsie peut être utilisée pour évaluer l'expression des antigènes HLA-D."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux maladies HLA-D ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, mais incluent fatigue, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les antigènes HLA-D causent-ils des symptômes directs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne causent pas de symptômes directs, mais sont liés à des maladies qui en provoquent."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient selon les antigènes HLA-D ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes dépendent de la maladie associée et des antigènes spécifiques présents."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires pour tous les HLA-D ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque antigène HLA-D peut être associé à des maladies différentes avec des symptômes variés."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils apparaître soudainement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans certaines maladies auto-immunes, les symptômes peuvent apparaître rapidement."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies liées aux HLA-D ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un diagnostic précoce et un suivi régulier peuvent aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les facteurs de risque connus et maintenir un mode de vie sain peuvent aider."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce des antigènes HLA-D peut aider à identifier les risques."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les antigènes HLA-D ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent moduler la réponse immunitaire, mais leur impact est variable."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies auto-immunes peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies HLA-D ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des immunosuppresseurs, des anti-inflammatoires et des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type d'HLA-D ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend de la maladie spécifique associée aux antigènes HLA-D."
}
},
{
"@type": "Question",
"name": "Les greffes nécessitent-elles un traitement immunosuppresseur ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients recevant une greffe doivent souvent prendre des immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Peut-on traiter les maladies HLA-D par des thérapies biologiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines thérapies biologiques ciblent spécifiquement les voies immunitaires impliquées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces pour tous les patients ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements peut varier selon le patient et la gravité de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec HLA-D ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le rejet de greffe, les infections et les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les maladies HLA-D peuvent-elles entraîner des complications graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies peuvent entraîner des complications graves, comme des lésions organiques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux HLA-D ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique un suivi médical régulier et des ajustements de traitement si nécessaire."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles, surtout avec un suivi médical approprié."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon les antigènes HLA-D ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier en fonction des antigènes HLA-D spécifiques impliqués."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies HLA-D ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections et des facteurs environnementaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'HLA-D ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies liées aux HLA-D sont plus fréquentes chez les adultes jeunes à moyens."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans les maladies HLA-D ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies sont plus fréquentes chez les femmes, comme le lupus érythémateux."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines peuvent réduire le risque de développer des maladies HLA-D."
}
},
{
"@type": "Question",
"name": "Les infections antérieures augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent déclencher des maladies auto-immunes chez les individus prédisposés."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/01/2026
Contenu vérifié selon les dernières recommandations médicales
7 publications dans cette catégorie
Affiliations :
The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA.
Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, USA.
7 publications dans cette catégorie
Affiliations :
The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
Department of Psychiatry, University of Minnesota Medical School, Minneapolis, MN, USA.
3 publications dans cette catégorie
Affiliations :
Faculty of Biology, Technion Israel Institute of Technology, Haifa, Israel admon@technion.ac.il Michael.peled@sheba.health.gov.il.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
The HLA Research Group, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN, USA.
Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Centre for Inflammatory Diseases, Monash University, Clayton, Victoria, 3168, Australia; Dept. of Nephrology, Monash Health, Clayton, Victoria, 3168, Australia; Dept. of Paediatric Nephrology, Monash Health, Clayton, Victoria, 3168, Australia.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Netherlands Proteomics Centre, Utrecht University, Utrecht, Netherlands.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Netherlands Proteomics Centre, Utrecht University, Utrecht, Netherlands.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Faculty of Biology, Technion Israel Institute of Technology, Haifa, Israel.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, United States.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Janssen Research & Development, Turnhoutseweg 30, BE-2340, Beerse, Belgium.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: sferrone@mgh.harvard.edu.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Protein Biochemistry, Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany. malvaro@zedat.fu-berlin.de.
Publications dans "Antigènes HLA-D" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Protein Biochemistry, Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Thielallee 63, 14195, Berlin, Germany. chfreund@zedat.fu-berlin.de.
Publications dans "Antigènes HLA-D" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Immunology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Publications dans "Antigènes HLA-D" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States.
Publications dans "Antigènes HLA-D" :
HLA class II antigen presentation is modulated by the activity of the peptide editor HLA-DM and its antagonist HLA-DO, with their interplay controlling the peptide repertoires presented by normal and ...
HLA-DMB allele frequencies and HLA-DBM-DRB1-DQB1 extended haplotypes were studied for the first time in Amerindians (Cuenca city area, Ecuador). It was found that most common extended haplotypes gathe...
Presentation of antigenic peptides by major histocompatibility complex class II (MHC-II) proteins determines T helper cell reactivity. The MHC-II genetic locus displays a large degree of allelic polym...
Host immunogenetics play a critical role in the human immune response to melanoma, influencing both melanoma prevalence and immunotherapy outcomes. Beneficial outcomes that stimulate T cell response h...
The aim of this study was to determine the Human Leukocyte Antigen (HLA) class II (...
CD4+ T cell responses are exquisitely antigen specific and directed toward peptide epitopes displayed by human leukocyte antigen class II (HLA-II) on antigen-presenting cells. Underrepresentation of d...
Cancer cell-killing by CD8+ T cells demands effective tumor antigen presentation by human leukocyte antigen class I (HLA-I) molecules. Screening and designing highly immunogenic neoantigens require qu...
Primary focal segmental glomerulosclerosis (FSGS), typically characterized by diffuse podocyte foot process effacement and nephrotic syndrome (diffuse podocytopathy), is generally attributed to a circ...
We report on a highly significant, positive association between anthrax vaccination and occurrence of Gulf War Illness (GWI) in 111 Gulf War veterans (42 with GWI and 69 controls). GWI was diagnosed i...
Bullous pemphigoid (BP) is an autoimmune blistering disease that mainly affects the elderly. The human leukocyte antigen (HLA) system is believed to be one of the genetic factors involved in the devel...